Variable
|
No readmission (%) (n = 74) | Readmission (%) (n = 36) | Total (%) (n = 110) |
Patient demographics | Patient demographics | Patient demographics | Patient demographics |
Median age (IQR) | 82 (72-92) | 83 (73-93) | 82 (73-91) |
Female | 47 (63.5) | 21 (58.3) | 68 (61.8) |
BOOST score and components | BOOST score and components | BOOST score and components | BOOST score and components |
BOOST (median ±IQR) | 3.0 ±2.0 | 4.0 ±2.0 | 4.0 ±1.0 |
Risk diagnosis |
53 (71.6)
|
31 (86.1)
|
84 (76.4)
|
Diabetes mellitus |
21 (28.4)
|
19 (52.8)
|
40 (36.4)
|
Cancer |
19 (25.7)
|
8 (22.2)
|
27 (24.5)
|
COPD |
15 (20.3)
|
9 (25.0)
|
24 (21.8)
|
Heart failure |
11 (14.9)
|
5 (13.9)
|
16 (14.5)
|
Stroke |
6 (8.1)
|
5 (13.9)
|
11 (10.0)
|
Problem Meds |
43 (58.1)
|
25 (69.4)
|
68 (61.8)
|
>9 medications |
17 (23.0)
|
15 (41.7)
|
32 (29.1)
|
Oral hypoglycaemics |
15 (20.3)
|
13 (36.1)
|
28 (25.5)
|
Anticoagulants |
16 (21.6)
|
6 (16.7)
|
22 (20.0)
|
Narcotics |
8 (10.8)
|
6 (16.7)
|
14 (12.7)
|
Insulin |
3 (4.1)
|
6 (16.7)
|
9 (8.2)
|
Digoxin |
4 (5.4)
|
1 (2.8)
|
5 (4.5)
|
Dual antiplatelet therapy |
2 (2.7)
|
3 (8.3)
|
5 (4.5)
|
Frailty |
38 (51.4)
|
25 (69.4)
|
63 (57.3)
|
Palliative |
35 (47.3)
|
20 (55.6)
|
55 (50.0)
|
Recent Hospitalisation |
26 (35.1)
|
26 (72.2)
|
52 (47.3)
|
Poor health literacy |
19 (25.7)
|
10 (27.8)
|
29 (26.4)
|
Poor patient support |
14 (18.9)
|
6 (16.7)
|
20 (18.2)
|
Depression History |
7 (9.5)
|
4 (11.1)
|
11 (10.0)
|
LACE index and components | LACE index and components | LACE index and components | LACE index and components |
LACE (median ±IQR) | 10.0 ±1.0 | 11.5 ±2.0 | 12.0 ±2.0 |
Median (IQR) length of stay score |
2 (1 to 3)
|
2 (0 to 4)
|
2 (1 to 3)
|
Emergency admission |
74 (100)
|
36 (100)
|
110 (100)
|
Median (IQR) comorbidity index score |
5 (5 to 5)
|
5 (5 to 5)
|
5 (5 to 5)
|
Median (IQR) recent attendance score |
0 (0 to 1)
|
1 (0 to 3)
|
0 (0 to 1)
|